Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × neratinib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasms 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1 Inflammatory Breast Neoplasms 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Endometrial Neoplasms 1

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡